Inhibitory effects of tetrahydroisoquinoline derivatives on Ca2+ and Na+ channels in crude nerve endings

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 3, 2000, Pages 375-378

  Zhang, Yu An ^a   Abe, Junnichi ^a   Wada, Tetsuyuki ^a   Ichida, Seiji ^a   Xu, Guo You ^b  

^a KINKI UNIVERSITY   (Japan)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Calcium ion channel; Calmodulin dependent phosphodiesterase (CaM PDE); Isoquinoline; Sodium ion channel

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM ION; CALMODULIN DEPENDENT PHOSPHODIESTERASE; NATURAL PRODUCT; OMEGA AGATOXIN VIA; OMEGA CONOTOXIN GVIA; PX 42; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CALCIUM TRANSPORT; CHICKEN; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; VOLTAGE CLAMP;

EID: 0034029555     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.375     Document Type: Article

References (24)

1. Xu G. Y., Peng S. X., Hua W. Y., J. China Pharm. Univ., 24, 1-6 (1993). (U.S.A. Chem. Abstr., Vol. 119: 139039p, 1993).
2. Xu G. Y., Peng S. X., Hua W. Y., J. China Pharm. Univ., 24, 1-6 (1993). (U.S.A. Chem. Abstr., Vol. 119: 139039p, 1993).
3. Xu G. Y. Peng S. X., Hua W. Y., J. China Pharm. Univ., 24, 193-201 (1993). (U.S.A. Chem. Abstr., Vol. 120: 244596m, 1994).
4. Xu G. Y. Peng S. X., Hua W. Y., J. China Pharm. Univ., 24, 193-201 (1993). (U.S.A. Chem. Abstr., Vol. 120: 244596m, 1994).
5. Lu Y. M., Frostl W., Dreessen J., Knopfel T., Neuroreport, 5, 1489-1492 (1994).
6. Lingenhohl K., Small D. L., Monette R., Buchan A. M., Morley P., Allegrini P. R., Frostl W., Sauer D., Schmutz M., Knopfel T., Neuropharmacol., 36, 107-113 (1997).
7. Dunlap K., Luebke J. I., Turner T. J., Trends Neurosci., 18, 89-98 (1995).
8. Artalejo C. R., Adams M. E., Fox A. P., Nature, 367, 72-76 (1994).
9. Plummer M. R., Logothetis D. E., Hess P., Neuron, 2, 1453-1463 (1989).
10. Cox D. H., Dunlap K., J. Neurosci., 12, 906-914 (1992).
11. Timothy J. T., Michael E. A., Kathleen D., Science, 258, 310-313 (1992).
12. Nishio H., Kumagaye K. Y., Kubo S., Chen Y., Momiyama A., Takahashi T., Kimura T., Sakakibara S., Biochem. Biophys. Res. Commun., 196, 1447-1453 (1993).
13. Gray E. F., Whittaker V. P., J. Anat., 96, 79-88 (1962).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Ichida S., Osugi T., Yoshida H., Life Sci., 29, 963-970 (1981).
16. Francois C., Nicole M. M., Annette K., Yoheved B. N., J. Neurosci., 6, 192-198 (1986).
17. Sharma R. K., Wang J. H., Adv. Cyclic Nucleotide Res., 10, 187-198 (1979).
18. Zhang Y., Imanishi T., Wata T., Ichida S., Neurochem. Res., 24, 1061-1068 (1999).
19. Amy L., Scott T. W., Daniel G., Bin L., Daniel R. S., Todd S., William A. C., Nature, 399, 155-159 (1999).
20. Roger D. Z., Geoffrey S. P., Karl D., Richard W. T., Harald R., Nature, 399, 159-162 (1999).
21. Hu Z. Y., Chen S. L., Hao Z. G., Huang W. L., Peng S. X., Cell Signal., 1, 181-185 (1989).
22. Armstrong C. M., Proc. Natl. Acad. Sci., 96, 4158-4163 (1999).
23. William A. C., Science, 242, 50-61 (1988).
24. Stefani A., Hainsworth A. H., Spadoni F., Bernardi G., Br. J. Pharmacol., 125, 1058-1064 (1998).